Therapeutic Benefit of <i>Vernonia amygdalina</i> in the Treatment of Diabetes and Its Associated Complications in Preclinical Studies.

Authors:
Asante DB; Wiafe GA.

Journal:
J Diabetes Res

Publication Year: 2023

DOI:
10.1155/2023/3159352

PMCID:
PMC10686711

PMID:
38033739

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Diabetes Res

Abbreviation: J Diabetes Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advances in Research Related to MicroRNA for Diabetic Retinopathy.
Luo Y; Li C. (2024) - Transparency Score: 3/6
Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients…
Lakić B; Škrbić R; Uletilović S and 9 more (2024) - Transparency Score: 3/6
Does Pre-existing Diabetes Correlate with Long COVID-19 in Europe? Evidence from the Analysis of th…
Cuschieri S; Wilk P. (2024) - Transparency Score: 3/6
Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabe…
Zhang Z; Fu X; Zhou F and 7 more (2024) - Transparency Score: 3/6
Pathology of Ketoacidosis in Emergency of Diabetic Ketoacidosis and Alcoholic Ketoacidosis: A Retro…
Koyama K; Anno T; Kimura Y and 4 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that there are no conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025